Streetbeat News

AMPE

Ampio Pharmaceuticals Inc

http://ampiopharma.com/

CEO

Michael Macaluso

Employees

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.

Open

0.00

Mkt cap

2.5K

Volume

635

High

0.00

P/E Ratio

N/A

52-wk high

7.47

Low

0.00

Div yield

N/A

52-wk low

0.00

LumiraDx Limited (NASDAQ:LMDX) shares plummeted over 30% in pre-market trading due to the announcement that its securities will be suspended from Nasdaq trading starting January 9th. Other stocks experienced significant movement in pre-market trading, with Harpoon Therapeutics, Inc. (NASDAQ:HARP) seeing a near 100% gain after reports of Merck's acquisition talks, and Spirit AeroSystems Holdings, Inc. (NYSE:SPR) dropping over 16% following the FAA's grounding of certain Boeing 737 Max 9 aircraft.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 1:20 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. Harpoon Therapeutics (HARP) saw a 110.9% increase, while Ambrx Biopharma (AMAM) rose by 101.76%. Vincerx Pharma (VINC) and Ampio Pharmaceuticals (AMPE) also gained, with increases of 52.54% and 27.52%, respectively. Cyclacel Pharmaceuticals (CYCC) and Axonics (AXNX) both saw their stocks rise by over 20%. Conversely, LumiraDx (LMDX) dropped by 32.6%, and other stocks such as Sharps Technology (STSS), Ainos (AIMD), Biofrontera (BFRI), Elevation Oncology (ELEV), and Cytokinetics (CYTK) also experienced declines.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 1:06 pm

In Friday's after-market session, several healthcare stocks experienced significant movements. Heart Test Laboratories (HSCS) saw a notable increase of 41.6%, while Sharps Technology (STSS) experienced a significant drop of 13.4%. Other gainers included MyMD Pharmaceuticals (MYMD), Asensus Surgical (ASXC), Journey Medical (DERM), Lucy Scientific Discovery (LSDI), and Ampio Pharmaceuticals (AMPE). On the losing side, Ainos (AIMD), Dermata Therapeutics (DRMA), Assertio Holdings (ASRT), CareMax (CMAX), and Synaptogenix (SNPX) saw declines in their stock prices.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 9:31 pm

DouYu International Holdings Limited (NASDAQ:DOYU) announced a share repurchase program of up to $20 million of ordinary shares in the form of ADSS, causing its shares to rise by 14.2% to $0.8320. Other stocks experienced significant movements in Thursday's mid-day session, with various companies seeing substantial gains and losses for diverse reasons, including FDA guidance, analyst ratings, public offerings, and patent lawsuit outcomes.

Portfolio Pulse from Avi Kapoor

December 28, 2023 | 6:07 pm

Bridgeline Digital, Inc. (NASDAQ:BLIN) shares fell by 13.1% in pre-market trading after reporting a narrower-than-expected loss for its fourth quarter but missing sales estimates. Other stocks experienced significant movements in pre-market trading, with Cingulate Inc. (NASDAQ:CING) and SenesTech, Inc. (NASDAQ:SNES) among the top gainers, while Rent the Runway, Inc. (NASDAQ:RENT) and Cyclo Therapeutics, Inc. (NASDAQ:CYTH) were among the top losers.

Portfolio Pulse from Avi Kapoor

December 28, 2023 | 1:22 pm

In Wednesday's after-market session, several healthcare stocks experienced significant movements. Cyclo Therapeutics (CYTH) saw a 34.1% increase, while Cingulate (CING) rose by 22.05%. Virax Biolabs Group (VRAX) and Inspire Veterinary (IVP) also saw gains of 10.69% and 8.64%, respectively. On the downside, Edgewise Therapeutics (EWTX) dropped by 14.5%, NKGen Biotech (NKGN) by 9.64%, and Panbela Therapeutics (PBLA) by 6.13%. Other losers included Ampio Pharmaceuticals (AMPE), Autolus Therapeutics (AUTL), and Nuwellis (NUWE) with declines of 5.91%, 5.9%, and 5.77%, respectively.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 9:31 pm

In Friday's after-market session, several healthcare stocks experienced significant movements. Lucy Scientific Discovery (LSDI) saw a 46.4% increase, while Lexeo Therapeutics (LXEO) rose by 23.53%. NexImmune (NEXI) and Virios Therapeutics (VIRI) also saw upward movements. Conversely, Telesis Bio (TBIO) and SeaStar Medical Holding (ICU) were among the stocks that fell, with declines of 15.4% and 11.46%, respectively.

Portfolio Pulse from Benzinga Insights

December 01, 2023 | 9:31 pm

Ampio Pharmaceuticals, Inc. (AMEX:AMPE) shares dropped significantly on Friday after a more than 200% spike on Thursday. The trading volume was more than double the 100-day average, with over 738 thousand shares traded. The company, which is developing treatments for severe Osteoarthritis of the Knee and COVID-19, has a small float of less than 815 thousand shares. The stock price fell by 44% to $3.20.

Portfolio Pulse from Erica Kollmann

December 01, 2023 | 6:46 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. NexImmune (NEXI) saw a dramatic increase of 540.4%, while Generation Bio (GBIO) and Altimmune (ALT) also posted substantial gains. Conversely, Ampio Pharmaceuticals (AMPE) and Intelligent Bio Solutions (INBS) were among the biggest losers, with sharp declines in their stock prices.

Portfolio Pulse from Benzinga Insights

December 01, 2023 | 5:31 pm

Genesco Inc. shares fell by approximately 20% following their quarterly results. The article also lists other stocks that moved significantly in Friday's mid-day session, categorizing them as gainers and losers. Notable gainers include Harbor Custom Development, Altimmune, and Elastic N.V., which rose due to positive trial results, financial results, and guidance, respectively. Among the losers, Polar Power experienced a significant drop after pricing a public offering, and Ampio Pharmaceuticals fell after a previous surge. The article provides a snapshot of the mid-day stock movements, highlighting the volatility and market reactions to company-specific news and broader market trends.

Portfolio Pulse from Lisa Levin

December 01, 2023 | 5:04 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.